Aphria Completes First Commercial Shipment of Medical M LEAMINGTON, ONTARIO--(Marketwired - Dec 11, 2014) - Aphria Inc. (TSX VENTURE:APH) is pleased to announce that it has completed its first commercial shipment of medical marijuana, just two weeks following the company's receipt of its final license from Health Canada.
"I am delighted to announce that initial demand for our product is strong and, with our first commercial sales and shipment of medical marijuana completed yesterday, we are officially open for business," said Vic Neufeld, Chief Executive Officer of Aphria. "Patients have been registering on our Aphria website since the moment we announced receipt of our license, and with close to 100 kilograms of product ready, or soon to be ready, we are geared up to satisfy the robust demand."
Aphria's three state-of-the-art light and computer controlled glass greenhouses are located within a 450,000 square foot greenhouse facility in Leamington, Ontario. Currently, Aphria has 22,000 square feet of production space with plans to significantly increase capacity in the next 12 to 24 months.
Added Neufeld, "Management has a long and proven track record of owning and operating large commercial scale greenhouse businesses. This invaluable experience together with the cost-saving attributes of our well-established greenhouse operations form the fundamental cornerstones of Aphria and provide us with key competitive advantages in the nascent Canadian medical marijuana industry."
About Aphria
Aphria, a company continued under the laws of the Province of Ontario and based in Leamington, Ontario, is in the business of producing, supplying and selling medical marijuana pursuant to the Marihuana for Medical Purposes Regulations (the "MMPR"). Under the MMPR, Health Canada is responsible for the oversight of commercial medical marijuana growers such as Aphria. Aphria's common shares are listed on the TSX Venture Exchange under the ticker symbol "APH".